7-valent pneumococcal conjugate vaccine
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00488826 | Oct 2005 → May 2007 | pneumococcal infection | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
| Phase 21 trial · 1 met primary | ||||||
| Phase 2 | NCT00148824 | Feb 2003 → Jan 2006 | HIV infectious disease | ANRS, Emerging Infectious Diseases | Completed | Met primary |
| Phase 31 trial | ||||||
| Phase 3 | NCT00213265 | Jul 2002 → Feb 2017 | disease related to solid organ transplantation | The Hospital for Sick Children | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01135082 | Apr → Dec 2010 | HIV infectious disease | The HIV Netherlands Australia Thailand Research Collaboration | Completed | No outcome recorded |
| Comparator or background therapy16 trials | ||||||
| Phase 1/2 | NCT00205803 Comparator | Sep 2004 → May 2007 | pneumococcal infection | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
| Phase 2 | NCT00689351 Comparator | Jun 2008 → Dec 2009 | — | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT02736240 Comparator | Apr 2016 → Dec 2017 | pneumococcal infection | Walvax Biotechnology Co., Ltd. | Completed | No outcome recorded |
| Phase 3 | NCT01692886 Comparator | Sep 2012 → Apr 2014 | pneumococcal infection | Pfizer | Completed | Met primary |
| Phase 3 | NCT01200368 Comparator | Sep 2010 → Nov 2011 | — | Pfizer | Completed | Met primary |
| Phase 3 | NCT00688870 Comparator | Jun 2008 → Jan 2010 | — | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00676091 Comparator | Apr 2008 → Sep 2009 | — | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00508742 Comparator | Dec 2007 → Aug 2011 | pneumococcal infection | Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00474539 Comparator | Jul 2007 → Mar 2009 | — | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00475033 Comparator | Jun 2007 → May 2009 | — | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00452790 Comparator | Jun 2007 → Oct 2009 | pneumococcal infection | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00366340 Comparator | Oct 2006 → Aug 2008 | — | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00366678 Comparator | Oct 2006 → Nov 2008 | — | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00366899 Comparator | Oct 2006 → Jul 2008 | — | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00368966 Comparator | Oct 2006 → Jul 2008 | — | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
| Phase 4 | NCT01346007 Comparator | Jan 2009 → Jun 2010 | idiopathic nephrotic syndrome | National and Kapodistrian University of Athens | Unknown | No outcome recorded |
Press releases naming this drug 15 releases
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 29 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 7-valent pneumococcal conjugate vaccine | “This study aimed to determine the immunogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV-7) in Thai HIV-infected children compared to HIV-exposed...” PMID 21729732 ↗ Jul 201120“BACKGROUND: Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine (PCV13) were compared with 7-valent pneumococcal conjugate vaccine (PCV7) in Chinese infants.” PMID 27254028 ↗ Sep 2016 |
| Known as | 7 - valent PCV | “In Thailand, 7 - valent PCV (Prevnar® ) was available in 2003.” NCT01135082 ↗ |
| Known as | 7vPnC | “The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate (13vPnC) vaccine compared to 7-valent pneumococcal...” NCT00366340 ↗8“The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate (13vPnC) vaccine compared to Prevenar (7vPnC), when...” NCT00366899 ↗ “The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate (13vPnC) vaccine compared to Prevenar (7vPnC), when...” NCT00474539 ↗ “The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate (13vPnC) vaccine compared to Prevenar (7vPnC), when...” NCT00368966 ↗ “The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate (13vPnC) vaccine compared to Prevenar (7vPnC), when...” NCT00366678 ↗ “7-Valent Pneumococcal Conjugate Vaccine (7vPnC)in healthy Chinese infants” NCT00488826 ↗ “7-Valent Pneumococcal Conjugate Vaccine (7vPnC)” NCT00205803 ↗ “7-Valent Pneumococcal Conjugate Vaccine (7vPnc)” NCT00676091 ↗ “7-valent pneumococcal conjugate vaccine (7vPnC)” NCT00688870 ↗ |
| Known as | PCV | “a 7-valent conjugate pneumococcal vaccine (PCV)” PMID 18025879 ↗ Nov 2007 |
| Known as | PCV7 | “The 7-valent pneumococcal conjugate vaccine (PCV7) has demonstrated effectiveness against pneumococcal illnesses when administered as 3 infant doses plus a toddler dose (3+1...” PMID 23965217 ↗ Aug 20137“Invasive pneumococcal disease rates have declined since immunization with 7-valent pneumococcal conjugate vaccine (PCV7) (Prevenar/Prevnar [Wyeth Pharmaceuticals, Philadelphia,...” PMID 20435707 ↗ May 2010 “This study aimed to determine the immunogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV-7) in Thai HIV-infected children compared to HIV-exposed...” PMID 21729732 ↗ Jul 2011 “BACKGROUND: Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine (PCV13) were compared with 7-valent pneumococcal conjugate vaccine (PCV7) in Chinese infants.” PMID 27254028 ↗ Sep 2016 “The immunogenicity and safety of 13-valent and 7-valent pneumococcal conjugate vaccines (PCV13 and PCV7) were compared when administered with routine vaccines in Korea.” PMID 23011012 ↗ Mar 2013 “13-Valent pneumococcal conjugate vaccine (PCV13) provides broader protection against pneumococcal disease than 7-valent pneumococcal conjugate vaccine (PCV7).” PMID 26121200 ↗ Oct 2015 “Immunogenicity and safety of 13-valent and 7-valent pneumococcal conjugate vaccines (PCV13; PCV7) were compared in Taiwanese children.” PMID 22198517 ↗ Dec 2011 “currently licensed 7-valent pneumococcal conjugate vaccine (PCV7)” PMID 27798013 ↗ Oct 2016 |
| Known as | Prevenar | “The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate (13vPnC) vaccine compared to Prevenar (7vPnC), when...” NCT00474539 ↗4“The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate (13vPnC) vaccine compared to Prevenar (7vPnC), when...” NCT00366899 ↗ “The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate (13vPnC) vaccine compared to Prevenar (7vPnC), when...” NCT00368966 ↗ “The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate (13vPnC) vaccine compared to Prevenar (7vPnC), when...” NCT00366678 ↗ “Invasive pneumococcal disease rates have declined since immunization with 7-valent pneumococcal conjugate vaccine (PCV7) (Prevenar/Prevnar [Wyeth Pharmaceuticals, Philadelphia,...” PMID 20435707 ↗ May 2010 |
| Known as | Prevenar/Prevenar | “The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate (13vPnC) vaccine compared to 7-valent pneumococcal...” NCT00366340 ↗ |
| Known as | PrevenarTM | “Pneumococcal 7-Valent Conjugate Vaccine [DIPHTHERIA CRM197 PROTEIN] (PrevenarTM) in Healthy Infants” NCT00488826 ↗ |
| Known as | Prevnar | “Invasive pneumococcal disease rates have declined since immunization with 7-valent pneumococcal conjugate vaccine (PCV7) (Prevenar/Prevnar [Wyeth Pharmaceuticals, Philadelphia,...” PMID 20435707 ↗ May 20101“In Thailand, 7 - valent PCV (Prevnar® ) was available in 2003.” NCT01135082 ↗ |
| Modality | Vaccine | “7-valent pneumococcal conjugate vaccine (vaccine)” NCT00148824 ↗ |
| Route | Intramuscular | “administered IM” NCT00676091 ↗ |